Hormonal and Ultrasonic Monitoring of Follicular Development and Ultrasound-guided Follicular Puncture

Author(s):  
L. Nilsson ◽  
L. Hamberger ◽  
P. O. Janson ◽  
M. Wikland
1986 ◽  
Vol 7 (7) ◽  
pp. 373-379 ◽  
Author(s):  
Peter Axelrod ◽  
George H. Talbot

In vitro fertilization and embryo transfer (IVF-ET) is a process in which human ova are obtained by laparoscopic ovarian follicular puncture, fertilized in vitro by capacitated donor sperm, and introduced transcervically into the uterus. The prospective mother's ovarian cycle is usually stimulated with either clomiphene citrate, human menopausal gonadotropin, or both, so that multiple aspiratable follicles are produced. Follicular development is monitored by ultrasound and by serial serum or urine estrogen determinations. When adequate follicular development has been achieved, a pre-ovulatory dose of human chorionic gonadotropin is administered.


2005 ◽  
Vol 17 (2) ◽  
pp. 255
Author(s):  
J.H.M. Viana ◽  
L.S.A. Camargo ◽  
A.M. Ferreira ◽  
W.F. Sa ◽  
C.A.C. Fernandes ◽  
...  

Ultrasound-guided follicular puncture (OPU) has become the most used technique to recover cumulus-oocyte complexes (COCs) from valuable donors for in vitro embryo production, because of the low risk and the possibility of collecting COCs at intervals as short as twice-a-week. However, repeated aspiration of ovarian follicles may induce endocrine abnormalities due to partial luteinization of punctured follicles and interference with follicular development. The use of exogenous progestagens is an alternative used to control these side effects, and is under evaluation. The aim of this study was to evaluate whether the effect of norgestomet treatment on intra-follicular and systemic steroid concentrations and on ovarian follicular dynamics is related to changes in LH releasing pattern. Pluriparous non-lactating Gir breed (Bos indicus) cows (n = 10) were randomly distributed between treatment (norgestomet ear implants, replaced weekly) and control (no hormone used) groups, and had their ovarian follicles larger than 3 mm in diameter aspirated twice a week, during the next two consecutive weeks. Follicular dynamics were evaluated every 12 h between OPU sessions, and the largest follicles present were used to recover samples of follicular fluid. Blood samples were collected daily for progesterone evaluation in all cows, and 3 times within a 4-h window interval, at 24, 48, 72, and 96 h after follicle puncture for LH evaluation, in 6 cows (3 from treated and 3 from control groups). LH was measured by a standardized RIA procedure. Data was analyzed by ANOVA, and means were compared by Tukey's test. Results are presented as means ± SEM. Treatment with norgestomet reduced mean progesterone plasma concentration during the evaluated period (36.3 ± 14.0 vs. 250.3 ± 49.3 pg/mL; P < 0.0001), the incidence of follicles growing above 9 mm (30% vs. 65%; P < 0.05) in the intervals between OPU sessions, and intrafollicular estradiol and progesterone concentrations in the largest follicles (n = 27) present (265.5 ± 47.4 and 34.9 ± 5.4 ng/mL vs. 765.2 ± 169.1 and 173.3 ± 43.4 ng/mL, respectively; P < 0.05). Plasma LH concentrations were consistently lower during the 3 session intervals in cows treated with norgestomet (0.16 ± 0.04, 0.22 ± 0.03, 0.22 ± 0.09 and 0.17 ± 0.01 vs. 0.44 ± 0.15, 0.53 ± 0.04, 0.42 ± 0.05 and 0.39 ± 0.11 for 24, 48, 72, and 96 h after OPU, respectively; P < 0.05). These results confirm the theory that norgestomet treatment is associated with a reduction in the LH-release pattern, as expected due to the reduction in both luteinization of punctured follicles and in the steroidogenic activity of growing follicles observed during the experiment. The use of norgestomet ear implants can be an alternative in the management of donor cows undergoing oocyte pickup. This work was sponsored by FAPEMIG and CNPq. The authors thank Dr. Robert Douglas for aiding with LH RIA.


2005 ◽  
Vol 17 (2) ◽  
pp. 312
Author(s):  
O. Algriany ◽  
P. Vos ◽  
H. Groenendaal ◽  
A. van Gastel ◽  
B. Colenbrander ◽  
...  

Multiple preovulatory follicles developing upon superovulation (SO) are heterogeneous in quality, which may be the consequence of follicular development deviating from that in untreated cyclic cows. Therefore, we investigated follicle performance in terms of estradiol (E), progesterone (P), and testosterone (T) concentrations in the fluid of stimulated preovulatory follicles (FF), in particular at onset of final maturation as initiated by the LH surge. Pre-synchronized HF cows (n = 25) were treated with oFSH (Ovagen; ICP, Auckland, New Zealand) for SO, and FF were collected 2 h pre-LH surge (n = 9 cows), and 6 h (n = 8) and 22 h C(n = 8) post-LH. At Day 9 (estrus = Day 0), a norgestomet ear implant (Crestar; Intervet International BV, Boxmeer, The Netherlands) was inserted, and SO treatment was started at Day 10 using oFSH i.m. twice daily in decreasing doses during 4 days (total dose 17 mL). Prostaglandin (22.5 mg PG; Prosolvin, Intervet) was administered i.m. concomitant with the 5th dose of FSH. Ear implants were removed 50 h after PG and then GnRH (0.021 mg Receptal; Intervet) was administered i.m. inducing the LH surge 2 h later. Ovaries were collected by laparotomy at the time of GnRH, and 8 and 24 h later and all follicles sized >10 and <16 mm were aspirated to collect FF (pre-LH, n = 79; 6 h post-LH, n = 78; and 22 h post LH, n = 78 follicles). For comparison, E and P in FF from pre-LH groups that had been collected previously in 2 other experiments of our group were studied: (1)86 FF collected by ultrasound-guided aspiration of follicles >8 mm from 23 cows at 30 h after PG, that is, preceding the LH surge, following treatment with 3000 IU eCG i.m. (Folligon; Intervet) on Day 10 and 15 mg PG on Day 12; (2) 12 FF of the dominant follicle from 12 untreated cyclic cows after ovariectomy 48 to 62 h after onset of luteolysis, that is, shortly before the natural LH surge. The concentrations (ng/mL FF) of E, P, and T were estimated by our validated RIAs. Data (mean ± SEM) were analyzed by ANOVA. The levels of E, P and T of the oFSH group were pre-LH: 399 ± 35, 49 ± 6 and 13 ± 2; 6 h post-LH: 194 ± 11, 202 ± 12, and 14 ± 1; and 22 h post-LH: 35 ± 2, 200 ± 23, and 7 ± 1, respectively. Although the change in E and P levels between the different time points after LH is in agreement with that reported for untreated cyclic cows (Dieleman et al. 1983 J.Endocrinol. 97, 31–42), the concentrations were lower. However, the most striking finding was the significantly lower E in pre-LH FF after oFSH compared to that after eCG (1302 ± 82) or of cyclic cows (1942 ± 200). The P levels in FF of the respective pre-LH groups were not significantly different. The much lower E level after oFSH is possibly due to the low or even absent LH bioactivity for oFSH in comparison to eCG. It could also indicate a lower developmental potential of oocytes following oFSH. However, it is known that SO with oFSH results in regular yields of transferable embryos similar to that after eCG. In view of the high variability of the E level in FF, it is concluded that selection of follicles for high E levels is a prerequisite when investigating oocyte development and maturation.


Author(s):  
P. Bagavandoss ◽  
JoAnne S. Richards ◽  
A. Rees Midgley

During follicular development in the mammalian ovary, several functional changes occur in the granulosa cells in response to steroid hormones and gonadotropins (1,2). In particular, marked changes in the content of membrane-associated receptors for the gonadotropins have been observed (1).We report here scanning electron microscope observations of morphological changes that occur on the granulosa cell surface in response to the administration of estradiol, human follicle stimulating hormone (hFSH), and human chorionic gonadotropin (hCG).Immature female rats that were hypophysectcmized on day 24 of age were treated in the following manner. Group 1: control groups were injected once a day with 0.1 ml phosphate buffered saline (PBS) for 3 days; group 2: estradiol (1.5 mg/0.2 ml propylene glycol) once a day for 3 days; group 3: estradiol for 3 days followed by 2 days of hFSH (1 μg/0.1 ml) twice daily, group 4: same as in group 3; group 5: same as in group 3 with a final injection of hCG (5 IU/0.1 ml) on the fifth day.


2001 ◽  
Vol 120 (5) ◽  
pp. A559-A559
Author(s):  
J HAENSLER ◽  
A RAIBLE ◽  
W HOLTKAMP ◽  
M FRAUENDORF ◽  
A WITTE ◽  
...  

2001 ◽  
Vol 120 (5) ◽  
pp. A475-A475
Author(s):  
M SAILER ◽  
D BUSSEN ◽  
M KRAEMER ◽  
M FEIN ◽  
S FREYS ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document